The product is both safe for home and can be used in a clinical setting...make the blood start clotting immediately...coming to the Internet or drug store soon...BD
Research Triangle Park, N.C. — Entegrion, a medical technology firm utilizing technology developed at the University of North Carolina at Chapel Hill and East Carolina University, has received Food and Drug Administration approval for one of its wound treatment products.
Stasilon FR is a hemostatic dressing that is designed to promote blood coagulation. It will be available over the counter as well as through prescriptions.
Entegrion is also developing other hemorrhage control technology, including gels and sprays for tissue repair, infusible treatments for control of internal hemorrhage and targeted drug delivery to tumors and internal bleeding.